Trugman JM - Search Results

1

Caffeine and progression of Parkinson disease.

Simon DK, Swearingen CJ, Hauser RA, Trugman JM, Aminoff MJ, Singer C, Truong D, Tilley BC; NET-D Investigators. Simon DK, et al. Among authors: trugman jm. Clin Neuropharmacol. 2008 Jul-Aug;31(4):189-96. doi: 10.1097/WNF.0b013e31815a3f03. Clin Neuropharmacol. 2008. PMID: 18670242 Free PMC article. Clinical Trial.

2

A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.

NINDS NET-PD Investigators. NINDS NET-PD Investigators. Clin Neuropharmacol. 2008 May-Jun;31(3):141-50. doi: 10.1097/WNF.0b013e3181342f32. Clin Neuropharmacol. 2008. PMID: 18520981 Free PMC article. Clinical Trial.

3

Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.

Elm JJ; NINDS NET-PD Investigators. Elm JJ, et al. Mov Disord. 2012 Oct;27(12):1513-21. doi: 10.1002/mds.25175. Mov Disord. 2012. PMID: 23079770 Free PMC article. Clinical Trial.

4

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.

Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM; NET-PD Investigators. Parashos SA, et al. JAMA Neurol. 2014 Jun;71(6):710-6. doi: 10.1001/jamaneurol.2014.391. JAMA Neurol. 2014. PMID: 24711047 Free PMC article. Clinical Trial.

5

Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations.

Hauser RA, Shulman LM, Trugman JM, Roberts JW, Mori A, Ballerini R, Sussman NM; Istradefylline 6002-US-013 Study Group. Hauser RA, et al. Among authors: trugman jm. Mov Disord. 2008 Nov 15;23(15):2177-85. doi: 10.1002/mds.22095. Mov Disord. 2008. PMID: 18831530 Clinical Trial.

6

Fatigue in levodopa-naive subjects with Parkinson disease.

Schifitto G, Friedman JH, Oakes D, Shulman L, Comella CL, Marek K, Fahn S; Parkinson Study Group ELLDOPA Investigators. Schifitto G, et al. Neurology. 2008 Aug 12;71(7):481-5. doi: 10.1212/01.wnl.0000324862.29733.69. Neurology. 2008. PMID: 18695158 Free PMC article. Clinical Trial.

7

Clinical correlates of sleep benefit in Parkinson's disease.

Currie LJ, Bennett JP Jr, Harrison MB, Trugman JM, Wooten GF. Currie LJ, et al. Among authors: trugman jm. Neurology. 1997 Apr;48(4):1115-7. doi: 10.1212/wnl.48.4.1115. Neurology. 1997. PMID: 9109914

8

Early morning dystonia in Parkinson's disease.

Currie LJ, Harrison MB, Trugman JM, Bennett JP Jr, Wooten GF. Currie LJ, et al. Among authors: trugman jm. Neurology. 1998 Jul;51(1):283-5. doi: 10.1212/wnl.51.1.283. Neurology. 1998. PMID: 9674823

9

Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease.

Rascol O, Nutt JG, Blin O, Goetz CG, Trugman JM, Soubrouillard C, Carter JH, Currie LJ, Fabre N, Thalamas C, Giardina WW, Wright S. Rascol O, et al. Among authors: trugman jm. Arch Neurol. 2001 Feb;58(2):249-54. doi: 10.1001/archneur.58.2.249. Arch Neurol. 2001. PMID: 11176963 Clinical Trial.

10

Postmenopausal estrogen use affects risk for Parkinson disease.

Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF. Currie LJ, et al. Among authors: trugman jm. Arch Neurol. 2004 Jun;61(6):886-8. doi: 10.1001/archneur.61.6.886. Arch Neurol. 2004. PMID: 15210525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters